Primary epithelial ovarian carcinoma in Taiwanese women

被引:0
|
作者
Wang, PH
Yuan, CC
Juang, CM
Lai, CR
Yen, MS
Chao, HT
Ng, HT
机构
[1] Vet Gen Hosp, Dept Obstet & Gynecol, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan
关键词
epithelial ovarian carcinoma; multivariate and univariate analyses; prognosis;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of investigation: Primary epithelial ovarian carcinoma is common in industrial countries but rare in the Orient. In fact, it is still a rare disease in Taiwan. In this article, we report the general data of Taiwanese patients with primary epithelial ovarian carcinoma. Methods: In this retrospective study we used univariate and multivariate analysis models: to analyze the prognosis of patients with surgically confirmed primary epithelial ovarian carcinoma. One hundred and ninety-four patients from 1990 to 1996 were identified and enrolled in this study. Results: The mean follow-up time was 44.7 months with an interval between 15.1 months and 105.9 months. Univariate analysis showed postmenopausal status, advanced stage, presence of lymph node metastasis, poor differentiation, and suboptimal surgery as risk factors for disease recurrence and subsequent deaths. Multivariate analysis demonstrated stage as the most important factor correlated with recurrent disease (risk ratio: 7.303 and 5.409, respectively), followed by optimal surgery (RR: 2.447), and cellular differentiation (RR: 1.677). Conclusions: Our data on the Taiwan population were consistent with other reports of different races. Early detection for primary epithelial ovarian cancer is of great importance because stage is still the most important predictor in disease-free survival and disease-related deaths. Application of the most reliable and acceptable methods of screening is our goal in the next century after weighing benefits over cents.
引用
收藏
页码:57 / 60
页数:4
相关论文
共 50 条
  • [31] Recurrent chromosome alterations in primary ovarian carcinoma in Chinese women
    Sham, JST
    Tang, TCM
    Fang, Y
    Sun, L
    Qin, LX
    Wu, QL
    Xie, D
    Guan, XY
    [J]. CANCER GENETICS AND CYTOGENETICS, 2002, 133 (01) : 39 - 44
  • [32] The status of KRAS mutations in primary ovarian clear cell carcinoma: An analysis of 17 Taiwanese patients
    Wang, Pi-Chieh
    Chao, Wan-Ru
    Tsai, Wen-Chih
    Lin, Yu-Hsuan
    Sheu, Gwo-Tarng
    Han, Chih-Ping
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2023, 62 (02): : 384 - 386
  • [33] Aflibercept in epithelial ovarian carcinoma
    Moroney, John W.
    Sood, Anil K.
    Coleman, Robert L.
    [J]. FUTURE ONCOLOGY, 2009, 5 (05) : 591 - 600
  • [34] Mucinous epithelial ovarian carcinoma
    Perren, T. J.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 : 53 - 57
  • [35] Whence epithelial ovarian carcinoma?
    Boyd, Jeff
    [J]. GYNECOLOGIC ONCOLOGY, 2008, 109 (02) : 161 - 163
  • [36] Farletuzumab in epithelial ovarian carcinoma
    Spannuth, Whitney A.
    Sood, Anil K.
    Coleman, Robert L.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 431 - 437
  • [37] Epithelial ovarian carcinoma - a perspective
    Renavikar, Pranav S.
    Chen, Jie
    Lele, Subodh M.
    [J]. JOURNAL OF HISTOTECHNOLOGY, 2023, 46 (02) : 55 - 56
  • [38] Cytoreductive surgery in the primary management of advanced epithelial ovarian carcinoma: A topic for debate
    Girling, JC
    Soutter, WP
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (02) : 81 - 84
  • [39] MRI for differentiating primary fallopian tube carcinoma from epithelial ovarian cancer
    Ma, Feng Hua
    Cai, Song Qi
    Qiang, Jin Wei
    Zhao, Shu Hui
    Zhang, Guo Fu
    Rao, Ya Min
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2015, 42 (01) : 42 - 47
  • [40] Is semen an etiologic factor in the development of primary peritoneal carcinoma and epithelial ovarian cancer?
    Maheshwari, A
    Gupta, S
    [J]. MEDICAL HYPOTHESES, 2005, 64 (02) : 264 - 266